Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Boers

Showing results (11-20 of 123) with videos related to

Pageof 13
Sort By:
Neuroscience Letters|January 30, 2002
Direct projections from the nucleus retroambiguus to cricothyroid motoneurons in the catJ Boers, E M Klop, A C Hulshoff, et al.
Kidney360|May 18, 2022
Kidney Injury in Patients Treated with Immune Checkpoint Inhibitors Does Not Meet KDIGO-AKI CriteriaMaartje F A Verploegen, Marye J Boers-Sonderen, Berber Piet, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 1, 2007
Mutations in methylenetetrahydrofolate reductase or cystathionine beta-synthase gene, or a high-methionine diet, increase homocysteine thiolactone levels in humans and miceGrazyna Chwatko, Godfried H J Boers, Kevin A Strauss, et al.
Clinical Chemistry and Laboratory Medicine|October 4, 2005
Reduced adenosine receptor stimulation as a pathogenic factor in hyperhomocysteinemiaNiels P Riksen, Gerard A Rongen, Henk J Blom, et al.
Anti-Cancer Drugs|February 2, 2012
A prolonged complete response in a patient with BRAF-mutated melanoma stage IV treated with the MEK1/2 inhibitor selumetinib (AZD6244)Marye J Boers-Sonderen, Ingrid M Desar, Willeke Blokx, et al.
Acta Oncologica (Stockholm, Sweden)|June 20, 2013
Capecitabine, irinotecan (CAPIRI) and sunitinib in metastatic colorectal cancerM J Boers-Sonderen, I M E Desar, M Koopman, et al.
British Journal of Pharmacology|February 11, 2004
Pharmacokinetic study on the utilisation of 5-methyltetrahydrofolate and folic acid in patients with coronary artery diseaseFrank F Willems, Godfried H J Boers, Henk J Blom, et al.
Journal of Molecular Biology|February 17, 2005
Molecular effects of homocysteine on cbEGF domain structure: insights into the pathogenesis of homocystinuriaSarah Hutchinson, Robin T Aplin, Heather Webb, et al.
Journal of the American College of Cardiology|September 3, 2002
Coronary endothelial function in hyperhomocysteinemia: improvement after treatment with folic acid and cobalamin in patients with coronary artery diseaseFrank F Willems, Wim R M Aengevaeren, Godfried H J Boers, et al.
Cardiovascular Research|August 12, 2003
Potential role for adenosine in the pathogenesis of the vascular complications of hyperhomocysteinemiaNiels P Riksen, Gerard A Rongen, Henk J Blom, et al.
Pageof 13

Showing results (11-20 of 123) with videos related to

Sort By:
Pageof 13
Neuroscience Letters|January 30, 2002
Direct projections from the nucleus retroambiguus to cricothyroid motoneurons in the catJ Boers, E M Klop, A C Hulshoff, et al.
Kidney360|May 18, 2022
Kidney Injury in Patients Treated with Immune Checkpoint Inhibitors Does Not Meet KDIGO-AKI CriteriaMaartje F A Verploegen, Marye J Boers-Sonderen, Berber Piet, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 1, 2007
Mutations in methylenetetrahydrofolate reductase or cystathionine beta-synthase gene, or a high-methionine diet, increase homocysteine thiolactone levels in humans and miceGrazyna Chwatko, Godfried H J Boers, Kevin A Strauss, et al.
Clinical Chemistry and Laboratory Medicine|October 4, 2005
Reduced adenosine receptor stimulation as a pathogenic factor in hyperhomocysteinemiaNiels P Riksen, Gerard A Rongen, Henk J Blom, et al.
Anti-Cancer Drugs|February 2, 2012
A prolonged complete response in a patient with BRAF-mutated melanoma stage IV treated with the MEK1/2 inhibitor selumetinib (AZD6244)Marye J Boers-Sonderen, Ingrid M Desar, Willeke Blokx, et al.
Acta Oncologica (Stockholm, Sweden)|June 20, 2013
Capecitabine, irinotecan (CAPIRI) and sunitinib in metastatic colorectal cancerM J Boers-Sonderen, I M E Desar, M Koopman, et al.
British Journal of Pharmacology|February 11, 2004
Pharmacokinetic study on the utilisation of 5-methyltetrahydrofolate and folic acid in patients with coronary artery diseaseFrank F Willems, Godfried H J Boers, Henk J Blom, et al.
Journal of Molecular Biology|February 17, 2005
Molecular effects of homocysteine on cbEGF domain structure: insights into the pathogenesis of homocystinuriaSarah Hutchinson, Robin T Aplin, Heather Webb, et al.
Journal of the American College of Cardiology|September 3, 2002
Coronary endothelial function in hyperhomocysteinemia: improvement after treatment with folic acid and cobalamin in patients with coronary artery diseaseFrank F Willems, Wim R M Aengevaeren, Godfried H J Boers, et al.
Cardiovascular Research|August 12, 2003
Potential role for adenosine in the pathogenesis of the vascular complications of hyperhomocysteinemiaNiels P Riksen, Gerard A Rongen, Henk J Blom, et al.
Pageof 13